AI-based patient digital twin system
A patient's digital twin isn't their electronic medical record. It's a computational model of a specific person's physiology that predicts treatment response before it's prescribed. The difference is fundamental: an EHR stores what has already happened. A digital twin simulates what would happen if X dose of Y drug were administered to a patient with a given genome, body composition, and comorbidities.
Levels of the patient's digital twin
Level 1: Integrated Profile
Aggregation of all available data into a single model: EHR (HL7 FHIR), genomic data (VCF files from NGS), wearable device data (Fitbit, Apple Watch — Heart Rate, HRV, SpO2, steps), dynamic lab results, imaging results (DICOM). Storage: FHIR server (HAPI FHIR, Azure Health Data Services) + specialized storage for genomics (Google BigQuery Genomics) and imaging.
Level 2: Predictive Models
ML models on top of the integrated profile: - Hospitalization prediction: LightGBM on time series of lab parameters + social factors. AUROC of 0.87 for 30-day hospitalization of CHF patients. - Exacerbation prediction: LSTM on wearable device data. Prediction of COPD exacerbation within 5 days: sensitivity of 0.79, specificity of 0.84. - Dose personalization: PK/PD (pharmacokinetic/pharmacodynamic) models + ML correction.
Level 3: Physiological Simulations
Organ-level simulation: a cardiac twin based on the Hodgkin-Huxley equations for ionic currents + FEM for cardiac mechanics. 0D/1D models of the systemic circulation. Patient-specific calibration using ECG and echocardiography data.
Personalization of pharmacotherapy
Pharmacokinetic/Pharmacodynamic modeling
The standard dosage is calculated for an "average" 70-kg patient. The actual patient weighs 94 kg, has impaired renal function (eGFR 42 ml/min/1.73 m²), and the CYP3A4 polymorphism (*1/*22) slows metabolism. Standard anticoagulant dose → risk of bleeding.
Architecture:
Геномные данные (CYP450 профиль)
+ Физиологические параметры (вес, функция органов)
+ Текущие препараты (DDI)
↓
PopPK/PD модель (NONMEMv7 или Monolix)
+ ML-коррекция на ИДЕальный data
↓
Байесовский апостериорный расчёт дозировки
↓
Рекомендация: доза, режим, мониторинг
The FDA has approved the first personalized dosing software system (DoseMeRx). Clinical trials have shown a reduction in the time to reach therapeutic warfarin concentrations from 5.4 to 2.8 days and a 31% reduction in bleeding events.
Oncology: Digital Twin of a Tumor
Prediction of response to chemotherapy
Tumor genomic profile (somatic mutations, CNVs, fusion genes) + histological data + prior treatment history → multimodal model. Graph Neural Network: nodes represent mutations and signaling pathways, edges represent interactions. Prediction of the objective response rate (ORR) for a specific chemotherapy regimen. Responder/non-responder classification accuracy: AUROC 0.81 on the TCGA dataset.
Tumor growth simulation
Differential equation of the tumor growth model (logistic, Gompertz) + ML calibration using serial imaging data (CT scans every 3 months). Prediction: when the tumor will reach a critical size in the absence of treatment vs. with regimen A vs. regimen B.
Chronic diseases and wearable devices
Closed-loop management of diabetes (T1D)
CGM (Continuous Glucose Monitor) data + insulin pump → Model Predictive Control (MPC) + ML: - Glycemia forecast for 60–120 min - Optimal bolus insulin dose based on planned meals and physical activity - Hypo/hyperglycemia prevention
Commercial systems (Medtronic 780G, Tandem t:slim X2 with Control-IQ) demonstrate: Time in Range (70–180 mg/dL) increases from 58% (manual) to 75–80% (closed-loop AI).
Privacy and regulatory requirements
HIPAA (US), GDPR (EU), and PDPA all require privacy-by-design. Federated Learning: models are trained on each hospital's data locally, with only gradients aggregated—patient data never leaves the institution. Differential Privacy (DP-SGD) provides additional protection.
FDA Software as a Medical Device (SaMD) regulatory pathway: Class II/III AI solutions require 510(k) or PMA submission. Regulatory development begins with a Software Development Plan (SDP) according to IEC 62304.
Development timeline: 6–12 months for Level 1-2 (integration + predictive models). Physiological simulations Level 3: 18–36 months, including clinical validation.